Vitalux

Manufacturer
PureTek Corporation
Effective date
2026-06-02
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-06-06 05:10:23

Label at a glance#

ProductVitalux
Active ingredientMAGNESIUM OXIDE, MANGANESE SULFATE, VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, CYANOCOBALAMIN, CALCIUM CARBONATE, FERROUS FUMARATE, ZINC OXIDE, MOLYBDENUM, CHOLINE BITARTRATE, SELENIUM, CHROMIUM NICOTINATE, POTASSIUM IODIDE
Label structure12 sections

Boxed warning

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient. Folate in doses above 0.1 mg daily may obs...

Indications and uses

Vitalux™ caplets are a prescription multivitamin formulated for the clinical dietary management of suboptimal nutritional status in patients where advanced folate, vitamin B supplementation, and maintenance of good health is needed. Vitalux™ caplets may be beneficial in improving the nutritional status of women prior to conception.

Dosage and administration

Adults (over 12 years of age): One (1) Vitalux™ caplet daily, preferably between meals, or as directed by a licensed healthcare practitioner. Do not administer to children under the age of 12.

Storage and handling

Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Protect from light and moisture and avoid excessive heat.

Label contents#

Full prescribing information#

Full Prescribing Information

DESCRIPTION SECTION

DESCRIPTION:

ACTIVE INGREDIENTS:

Each caplet contains:

Vitamin A (as retinyl acetate)……………….. 1500 mcg RAE (5000 IU)
Vitamin C (as ascorbic acid)…………………………….........… 120 mg
Vitamin D3 (as cholecalciferol)………………….......... 20 mcg (800 IU)
dl-Alpha-Tocopheryl Acetate (Vitamin E)……………...... 30 mg (30 IU)
Thiamin (as thiamine mononitrate)………………………...........… 3 mg
Riboflavin ..............................……………………………………. 3.4 mg
Niacin (as niacinamide)………………………………...........…… 20 mg
Vitamin B6 (as pyridoxine hydrochloride)…………........………. 50 mg
Folate (as L-5-Methyltetrahydrofolate calcium salt )…. 1700 mcg DFE
(1000 mcg L-Methylfolate)
Vitamin B12 (as cyanocobalamin)………………........………… 10 mcg
Choline (as choline bitartrate)………………………...........…….. 55 mg
Calcium (as calcium carbonate)……………………..........……. 200 mg
Iron (as ferrous fumarate)………………………………............… 27 mg
Iodine (as potassium iodine)…………………………...........… 150 mcg
Magnesium (as magnesium oxide)…………………..........…… 200 mg
Zinc (as zinc oxide)…………………………………............…….. 25 mg
Selenium (as selenium amino acid chelate)………......………. 70 mcg
Manganese (as manganese sulfate)………………........……… 2.6 mg
Chromium (as chromium polynicotinate)…………..........…….. 45 mcg
Molybdenum (as molybdenum amino acid chelate)…......…… 50 mcg


OTHER INGREDIENTS:
Croscarmellose sodium, crospovidone, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid, Clear coating (hydroxypropyl methylcellulose, polyethylene glycol 400).

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

Vitalux™ caplets are a prescription multivitamin formulated for the clinical dietary management of suboptimal nutritional status in patients where advanced folate, vitamin B supplementation, and maintenance of good health is needed. Vitalux™ caplets may be beneficial in improving the nutritional status of women prior to conception.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

This product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folate may obscure its signs and symptoms.

WARNING:

BOXED WARNING SECTION

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.

PRECAUTIONS:

PRECAUTIONS SECTION

Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.

There is a potential danger in administering folate to patients with undiagnosed anemia, since folate may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia.

The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.

DRUG INTERACTIONS:

DRUG INTERACTIONS SECTION

Vitalux™ caplets is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with antiplatelet agents (e.g., Aspirin, or Clopidogrel) and anticoagulants (e.g., Heparin).

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Folate: Allergic sensitizations have been reported following both oral and parenteral administration of folate.

Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals. Administration of Vitalux TM caplets after meals may reduce occasional gastrointestinal disturbances.

Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.

For use on the order of a licensed healthcare practitioner.
Call your licensed healthcare practitioner about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov-/medwatch.

OVERDOSE:

OVERDOSAGE SECTION

Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300 mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities, have resulted. Vitalux™ caplets should be stored beyond the reach of children to prevent against accidental iron poisoning.

Treatment:

SPL UNCLASSIFIED SECTION

For specific therapy, exchange transfusion and chelating agents should be used. For general management, perform gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Adults (over 12 years of age): One (1) Vitalux™ caplet daily, preferably between meals, or as directed by a licensed healthcare practitioner. Do not administer to children under the age of 12.

HOW SUPPLIED:

HOW SUPPLIED SECTION

Vitalux™ caplets are supplied as beige, oblong, film-coated caplets in bottles containing 30 caplets – NDC 59088-139-54. Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure.

STORAGE AND HANDLING SECTION

Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Protect from light and moisture and avoid excessive heat.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Do not use if the seal under the bottle cap is broken.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Manufactured by:
PureTek Corporation

Panorama City, CA 91402
For questions or information
call toll-free: 1-877-921-7873

labellabel

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130359088139547GTIN-13: 0359088139547
EAN-13: 0359088139547
GTIN-12: 359088139547
UPC-A: 359088139547
GTIN storage (14 digits): 00359088139547
Vitalux.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 43 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59088-13959088-139-54

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VitaluxMULTIVITAMINPureTek Corporation52d5eee7-8146-cc62-e063-6394a90a8c3f2026-06-02Boxed warning, Adverse reactionsExact identifier
ndc (package): 59088-139-54
ndc (product): 59088-139
ndc11 (package): 59088013954
spl id: 52d5fd35-3a68-5edd-e063-6394a90aba81
spl set id: 52d5eee7-8146-cc62-e063-6394a90a8c3f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.